25.12.2014 Views

David Watkins - The Royal Marsden

David Watkins - The Royal Marsden

David Watkins - The Royal Marsden

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong><br />

Maintenance rituximab in follicular lymphoma<br />

<strong>The</strong> use of maintenance rituximab significantly delays the time to<br />

disease progression<br />

2 nd Line<br />

Rituximab intravenously<br />

once every 3 months<br />

until relapse or for a<br />

maximum of 2 years<br />

NICE approved 2008<br />

1 st Line<br />

Rituximab intravenously<br />

once every 2 months<br />

until relapse or for a<br />

maximum of 2 years<br />

0 6 12 18 24 30 36 42 48 54 60

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!